Unicentric Plasma-Cell Type Castleman's Disease

References (9)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822-830.
2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
3. Bjarnason I, Cotes PM, Knowles S, Reid C, Wilkins R, Peters TJ. Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia. Gastroenterology 1984;87:216-223.
4. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic significance of interleukin-6 (IL-6/ BSF-2) in Castleman's disease. Blood 1989;74:1360-1367.
5. Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 2010;116:3627-3634.
6. Yin L, Lu XY, Xu F, Li AJ, Wu MC. Unicentric Castleman's disease presenting with growth retardation and iron deficiency anemia. Am J Med Sci 2012;343:426- 428. Chandrakasan S, Bakeer N, Mo JQ, Cost C, Quinn CT. Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children. J Pediatr 2014;164:928-930.
7. Suh JH, Hong SH, Jeong SC, Park CB, Choi KB, Shin OR, Choi SY. Anemia resolved by thoracoscopic resection of a mediastinal mass: a case report of unicentric Castleman's disease. J Thorac Dis 2015;7:189-193.
8. Vinzio S, Ciarloni L, Schlienger JL, Rohr S, Méchine A, Goichot B. Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway? Eur J Intern Med 2008;19:367-369.
9. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-1057.